Old Web
English
Sign In
Acemap
>
authorDetail
>
Mary Dianne Murphy
Mary Dianne Murphy
Food and Drug Administration
Medicine
Sildenafil
Health policy
Drug
Drug development
3
Papers
7
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil
2017
Circulation-cardiovascular Quality and Outcomes
Craig Sable
D. Dunbar Ivy
Robert H. Beekman
Helene D. Clayton-Jeter
Kathy J. Jenkins
William T. Mahle
William R. Morrow
Mary Dianne Murphy
Robert M. Nelson
Geoffrey L. Rosenthal
Norman Stockbridge
David L. Wessel
Show All
Source
Cite
Save
Citations (0)
2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil
2017
Journal of the American College of Cardiology
Craig Sable
D. Dunbar Ivy
Robert H. Beekman
Helene D. Clayton-Jeter
Kathy J. Jenkins
William T. Mahle
William R. Morrow
Mary Dianne Murphy
Robert M. Nelson
Geoffrey L. Rosenthal
Norman Stockbridge
David L. Wessel
Show All
Source
Cite
Save
Citations (1)
Pediatric post-marketing safety systems in North America: assessment of the current status†
2015
Pharmacoepidemiology and Drug Safety
Ann W. McMahon
Gerold T. Wharton
Renan Bonnel
Mary DeCelle
Kimberley Swank
Daniela Testoni
Judith U. Cope
Phillip Brian Smith
Eileen Wu
Mary Dianne Murphy
Show All
Source
Cite
Save
Citations (6)
1